Date of event
Continuing Education Credits
AASLD COVID-19 Clinical Oversight Subcommittee
American Society of Transplantation
- A. Sidney Barritt IV, MD, MSCR
University of North Carolina at Chapel Hill
- Olivia Kates, MD
University of Washington
- Elizabeth C. Verna, MD, MS
Columbia University Medical Center
- Emily Blumberg, MD, FAST
University of Pennsylvania
- Michael L. Schilsky, MD, FAASLD
- Michael Ison, MD, MS
- John C. Bucuvalas, MD, FAASLD
- Jean C. Emond, MD, FAASLD
As COVID-19 has had a profound impact on liver transplantation and patients with advanced chronic liver disease, the AASLD and American Society of Transplantation (AST) have teamed up to provide an update on the management of COVID-19 in transplant candidates and recipients.
This webinar will:
- Discuss emerging data on treatment and clinical outcomes among patients with chronic liver disease and cirrhosis with COVID-19
- Describe current approaches to treatment and immunosuppression adjustment in liver transplant recipients with COVID-19
- Consider whether clinical outcomes among liver transplant recipients are different then non-transplant patients with COVID-19
- Discuss the complex management decisions that occur in the peri-transplant period for patients with COVID-19
Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, June 23, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.
A. Sidney Barritt IV, MD, MSCR
A. Sidney Barritt IV, MD, MSCR, is an associate professor in the UNC liver center at the University of North Carolina. He is the interim medical director of liver transplantation and the transplant hepatology fellowship program director. Dr. Barritt conducts clinical outcomes research in nonalcoholic fatty liver disease (NAFLD), general hepatology, and liver transplantation. Dr. Barritt leads the UNC Liver Center’s clinical trial program in NAFLD where he is PI on multiple phase 2 and 3 industry sponsored clinical trials. Dr. Barritt is a collaborator and advisor to multiple other investigators in the allied schools of health, including the Gillings School of Global Public Health, the Eshelman School of Pharmacy and the UNC School of Dentistry. Outside of work, Dr. Barritt enjoys spending time with his family, road running, and triathlons.
Olivia Kates, MD
Dr. Olivia Kates is a second-year fellow in the Division of Allergy and Infectious Diseases at the University of Washington, and a developer and lead investigator in the UW COVID-SOT Registry project. In addition, Dr. Kates is pursuing a Masters degree in Bioethics and Humanities at the University of Washington, with research interests in the intersections of bioethics, transplantation, and infectious diseases.
Elizabeth C. Verna, MD, MS
Dr. Elizabeth Verna is an Associate Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University, where she practices as transplant hepatologist. In addition, Dr. Verna has an active clinical research program in end-stage liver disease and liver transplantation and is the Director of Clinical Research for the Columbia University Transplant Clinical Research Center.